Please use this identifier to cite or link to this item: 10.3389/fpsyt.2024.1382027
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaube, Māris-
dc.date.accessioned2024-03-19T14:35:04Z-
dc.date.available2024-03-19T14:35:04Z-
dc.date.issued2024-02-
dc.identifier.citationTaube , M 2024 , ' Editorial: Reviews in psychiatry 2022: psychopharmacology ' , Frontiers in Psychiatry , vol. 15 , 1382027 . https://doi.org/10.3389/fpsyt.2024.1382027-
dc.identifier.issn1664-0640-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/15375-
dc.format.extent254857-
dc.language.isoeng-
dc.relation.ispartofFrontiers in Psychiatry-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectantidepressant-
dc.subjectdepression-
dc.subjectschizophrenia-
dc.subjectsleep-
dc.subjectvortioxetine-
dc.subjectmetformin-
dc.subjectmicrodosing-
dc.subject3.3 Health sciences-
dc.subject3.2 Clinical medicine-
dc.subject3.5 Other medical sciences-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.titleEditorial: : Reviews in psychiatry 2022: psychopharmacologyen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/editorial-
dc.identifier.doi10.3389/fpsyt.2024.1382027-
dc.contributor.institutionDepartment of Psychiatry and Narcology-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85187893955&partnerID=8YFLogxK-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Editorial.pdf248.88 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.